ACADIA Pharmaceuticals Inc.
ACAD
$16.12
-$0.50-3.01%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 143.74M | 32.77M | 33.39M | 16.56M | 45.80M |
| Total Depreciation and Amortization | 5.21M | 2.57M | 2.57M | 5.53M | 1.64M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -138.88M | 23.42M | 13.73M | 12.96M | 16.24M |
| Change in Net Operating Assets | 30.31M | 4.49M | -24.68M | -5.97M | 21.71M |
| Cash from Operations | 40.38M | 63.25M | 25.01M | 29.08M | 85.39M |
| Capital Expenditure | -453.00K | -70.00K | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | 146.52M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.91M | -82.39M | -56.19M | -14.04M | -347.00K |
| Cash from Investing | 122.15M | -82.46M | -56.19M | -14.04M | -347.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.97M | 268.00K | 3.57M | 1.04M | 5.43M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.97M | 268.00K | 3.57M | 1.04M | 5.43M |
| Foreign Exchange rate Adjustments | -60.00K | -42.00K | 3.00K | 5.00K | -12.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 164.44M | -18.99M | -27.61M | 16.09M | 90.46M |
